200 related articles for article (PubMed ID: 28934253)
1. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
[TBL] [Abstract][Full Text] [Related]
2. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
HUANG XS; ZHAO SP; BAI L; ZHANG Q; HU M; ZHAO W
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):809-13. PubMed ID: 21092650
[TBL] [Abstract][Full Text] [Related]
3. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice.
Prieur X; Lesnik P; Moreau M; Rodríguez JC; Doucet C; Chapman MJ; Huby T
Biochim Biophys Acta; 2009 Aug; 1791(8):764-71. PubMed ID: 19362162
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
[TBL] [Abstract][Full Text] [Related]
6. The anti-hyperlipidemic effects of Poria cocos (Schw.) Wolf extract: Modulating cholesterol homeostasis in hepatocytes via PPARα pathway.
Zhang X; Lin W; Lei S; Zhang S; Cheng Y; Chen X; Lu Y; Zhao D; Zhang Y; Guo C
J Ethnopharmacol; 2024 Mar; 321():117532. PubMed ID: 38048892
[TBL] [Abstract][Full Text] [Related]
7. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
[TBL] [Abstract][Full Text] [Related]
9. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
[TBL] [Abstract][Full Text] [Related]
10. Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats.
Cao Y; Bei W; Hu Y; Cao L; Huang L; Wang L; Luo D; Chen Y; Yao X; He W; Liu X; Guo J
Phytomedicine; 2012 Jun; 19(8-9):686-92. PubMed ID: 22554715
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone regulates the hypotriglyceridemic gene APOA5.
Prieur X; Huby T; Coste H; Schaap FG; Chapman MJ; Rodríguez JC
J Biol Chem; 2005 Jul; 280(30):27533-43. PubMed ID: 15941710
[TBL] [Abstract][Full Text] [Related]
12. The effect of Xuezhikang capsule on gene expression profile in brown adipose tissue of obese spontaneously hypertensive rats.
Zhang S; Jiang Y; Wang X; Zhang H; Gu P; Gong Z; Jiang W; Zhang Y; Zhu Y
J Ethnopharmacol; 2023 Feb; 302(Pt A):115700. PubMed ID: 36126782
[TBL] [Abstract][Full Text] [Related]
13. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes.
Duncan RE; Archer MC
Lipids; 2008 Jul; 43(7):619-27. PubMed ID: 18509688
[TBL] [Abstract][Full Text] [Related]
14. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
15. Estrogen lowers triglyceride via regulating hepatic APOA5 expression.
Luo F; Guo Y; Ruan GY; Peng R; Li XP
Lipids Health Dis; 2017 Apr; 16(1):72. PubMed ID: 28376804
[TBL] [Abstract][Full Text] [Related]
16. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
Su X; Kong Y; Peng DQ
Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
Dorfmeister B; Brandlhofer S; Schaap FG; Hermann M; Fürnsinn C; Hagerty BP; Stangl H; Patsch W; Strobl W
Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
[TBL] [Abstract][Full Text] [Related]
18. [Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression].
Huang X; Li R; Chen L; Dai W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1389-1394. PubMed ID: 29317579
[TBL] [Abstract][Full Text] [Related]
19. Studies on the regulation of lipid metabolism and its mechanism of the iridoids rich fraction in Valeriana jatamansi Jones.
Zhu J; Xu K; Zhang X; Cao J; Jia Z; Yang R; Ma C; Chen C; Zhang T; Yan Z
Biomed Pharmacother; 2016 Dec; 84():1891-1898. PubMed ID: 27832992
[TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
